Latest Adverse effect Stories
TEMPLE, Texas, July 18, 2014 /PRNewswire/ -- Unique Pharmaceuticals, Ltd., ("Unique" or "the Company") today announced a voluntary nationwide recall of all sterile drug preparations compounded by the
GREENSBORO, N.C., July 3, 2014 /PRNewswire/ -- ConvaTec has announced that the U.S.
According to a recently published research letter from JAMA, the severe cutaneous reactions are typically experienced following use of a broad array of prescription and over-the-counter medications.
OTTAWA, May 23, 2014 /CNW/ - The issue: Pharmascience Inc., in consultation with Health Canada, is recalling one lot of PMS-Losartan-HCTZ due to a labelling error on the blister
OTTAWA, May 16, 2014 /CNW/ - The issue: One lot of Lite Fit USA (Lot Number 13165, Exp. 05/17) is being voluntarily recalled in the U.S. after analysis by the U.S.
FRAMINGHAM, Mass., May 1, 2014 /PRNewswire/ -- HeartWare International, Inc.
FRAMINGHAM, Mass., April 24, 2014 /PRNewswire/ -- HeartWare International, Inc.
New submission based on positive Phase 3 data from the RESONATE(TM) trial RARITAN, N.J., April 8, 2014 /PRNewswire/ -- Janssen Research & Development, LLC ("Janssen") today announced
PLEASANTON, Calif., March 17, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials
LEXINGTON, Massachusetts, March 14, 2014 /PRNewswire/ -- Shire Pharmaceuticals announced today the initiation of a voluntary recall in the United States of one batch, packaged
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).